Article Text
Abstract
Glial fibrillary acidic protein antibody-positive meningoencephalomyelitis is a newly described, possibly under-recognised, severe inflammatory condition of the nervous system. The clinical presentation is variable but most commonly is a combination of meningitis, encephalitis and myelitis; other manifestations may include seizures, psychiatric symptoms and tremor. There is a significant association with malignancies, often occult, and with other autoimmune conditions. Although the disease responds well to corticosteroids acutely, it typically relapses when these are tapered, and so patients need long-term immunosuppression. We report a young man presenting with subacute meningoencephalitis and subsequent myelitis, and discuss the typical presentation and management of this severe but treatable condition.
- immunology
- meningoencephalitis
- myelopathy
Statistics from Altmetric.com
Footnotes
Contributors All authors provided clinical care to the patient. AZ drafted the first version of the manuscript, and all authors contributed to and have approved the final version of the manuscript.
Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Jackie Palace, Oxford, UK.
Read the full text or download the PDF:
Other content recommended for you
- CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica
- Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders
- Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
- Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
- Neuromyelitis optica spectrum disorder as a paraneoplastic syndrome: a rare and challenging diagnosis
- Overlapping CNS inflammatory diseases: differentiating features of NMO and MS